+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Silenor"

Insomnia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Insomnia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 198 Pages
  • Global
From
Analyzing the Global CNS Market 2018 - Product Thumbnail Image

Analyzing the Global CNS Market 2018

  • Report
  • April 2018
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Silenor is a brand of central nervous system (CNS) drug used to treat insomnia. It is a non-benzodiazepine hypnotic, meaning it works by targeting certain receptors in the brain to induce sleep. It is used to treat difficulty falling asleep, staying asleep, and early morning awakenings. Silenor is taken orally, usually in the form of a tablet, and is generally taken shortly before bedtime. Silenor is a relatively new drug, having been approved by the U.S. Food and Drug Administration in 2010. It is marketed by Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company based in San Diego, California. Some other companies in the CNS drug market include Pfizer, Inc., GlaxoSmithKline, and Johnson & Johnson. Show Less Read more